Counseling on vaginal delivery of contraceptive hormones: implications for women’s body knowledge and sexual health

References

• Benagiano G, Bastianelli C, Farris M. Contraception today. Ann NY Acad Sci 2006;1092:1–32
   PubMed Web of Science ®Google Scholar
• Hooper DJ. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin Drug Investig 2010;30:749–63
   PubMed Web of Science ®Google Scholar
• Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999;59:277–86
   PubMed Web of Science ®Google Scholar
• Welsh MJ, Stanback J, Shelton J. Access to modern contraception. Best Pract Res Clin Obstet Gynaecol 2006;20:323–38
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Cho S, Inki P, et al. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counselling—results of an international survey in 10 countries. Contraception 2012;86:631–8
   PubMed Web of Science ®Google Scholar
• Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception 2007;76:267–72
   PubMed Web of Science ®Google Scholar
• van de Weijer P. What women want and what their doctors need—how do women evaluate the quality of contraceptive methods and products introduced by their gynaecologist? A different perspective. Eur J Contracept Reprod Health Care 2005;10:2–6
   PubMed Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404
   PubMed Web of Science ®Google Scholar
• Bitzer J, Simon JA. Current issues and available options in combined hormonal contraception. Contraception 2011;84:342–56
   PubMed Web of Science ®Google Scholar
• Trussell J. Understanding contraceptive failure. Best Pract Res Clin Obstet Gynaecol 2009;23:199–209
   PubMed Web of Science ®Google Scholar
• Moos MK, Bartholomew NE, Lohr KN. Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda. Contraception 2003;67:115–32
   PubMed Web of Science ®Google Scholar
• Bitzer J, Gemzell-Danielsson K, Roumen F, et al. The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Health Care 2012;17:657–68
   Web of Science ®Google Scholar
• Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001;64:51–8
   PubMed Web of Science ®Google Scholar
• Nappi R, Salonia A, Traish AM, et al. Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med 2005;2:4–25
   PubMed Web of Science ®Google Scholar
• van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception 2005;72:168–74
   PubMed Web of Science ®Google Scholar
• Rosenberg M, Waugh MS. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 1999;180:276–9
   PubMed Web of Science ®Google Scholar
• Roumen FJ, Mishell DR Jr. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Eur J Contracept Reprod Health Care 2012;17:415–27
   PubMed Web of Science ®Google Scholar
• Alexander NJ, Baker E, Kaptein M, et al. Why consider vaginal drug administration? Fertil Steril 2004;82:1–12
   PubMed Web of Science ®Google Scholar
• Mishell DR Jr, Lumkin ME. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings. Fertil Steril 1970;21:99–103
   PubMed Web of Science ®Google Scholar
• Wieder DR, Pattimakiel L. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing). Int J Womens Health 2010;2:401–9
   PubMedGoogle Scholar
• Roumen F. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. Eur J Contracept Reprod Health Care 2002;7:19–24; discussion 37–9
   Web of Science ®Google Scholar
• Roumen FJ. Review of the combined contraceptive vaginal ring, NuvaRing. Ther Clin Risk Manag 2008;4:441–51
   PubMedGoogle Scholar
• Brache V, Faundes A. Contraceptive vaginal rings: a review. Contraception 2010;82:418–27
   PubMed Web of Science ®Google Scholar
• Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585–93
   PubMed Web of Science ®Google Scholar
• Oddsson K, Leifels-Fischer B, de Melo NR, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomised trial. Contraception 2005;71:176–82
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Nisand I, Bastianelli C, et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception 2006;74:451–7
   PubMed Web of Science ®Google Scholar
• Milsom I, Lete I, Bjertnaes A, et al. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Hum Reprod 2006;21:2304–11
   PubMed Web of Science ®Google Scholar
• Bjarnadóttir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 2002;186:389–95
   PubMed Web of Science ®Google Scholar
• Oddsson K, Leifels-Fischer B, Wiel-Masson D, et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomised trial. Hum Reprod 2005;20:557–62
   PubMed Web of Science ®Google Scholar
• Roumen FJ, Op ten Berg MM, Hoomans EH. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands. Eur J Contracept Reprod Health Care 2006;11:14–22
   PubMed Web of Science ®Google Scholar
• Novák A, de la Loge C, Abetz L, van der Meulen EA. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception 2003;67:187–94
   PubMed Web of Science ®Google Scholar
• Brucker C, Karck U, Merkle E. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany. Eur J Contracept Reprod Health Care 2008;13:31–8
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS, Hund M. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. Eur J Contracept Reprod Health Care 2010;15:413–22
   PubMed Web of Science ®Google Scholar
• Egarter C, Grimm C, Nouri K, et al. Contraceptive counselling and factors affecting women's contraceptive choices: results of the CHOICE study in Austria. Reprod Biomed Online 2012;24:692–7
   PubMed Web of Science ®Google Scholar
• Victor I, Fink RA. Comparing patient telephone callback rates for different hormonal birth control delivery systems. Am J Ther 2006;13:507–12
   PubMedGoogle Scholar
• Nappi RE, Liekens G, Brandenburg U. Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey. Contraception 2006;73:493–500
   PubMed Web of Science ®Google Scholar
• Terrell LR, Tanner AE, Hensel DJ, et al. Acceptability of the vaginal contraceptive ring among adolescent women. J Pediatr Adolesc Gynecol 2011;24:204–10
   PubMed Web of Science ®Google Scholar
• Tepe M, Mestad R, Secura G, et al. Association between tampon use and choosing the contraceptive vaginal ring. Obstet Gynecol 2010;115:735–9
   PubMed Web of Science ®Google Scholar
• Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet 2006;273:195–202
   PubMedGoogle Scholar
• Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425–7
   PubMed Web of Science ®Google Scholar
• Sobecki JN, Curlin FA, Rasinski KA, Lindau ST. What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists. J Sex Med 2012;9:1285–94
   PubMed Web of Science ®Google Scholar
• Eschenbach DA, Patton DL, Meier A, et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 2000;62:107–12
   PubMed Web of Science ®Google Scholar
• Jespers V, Menten J, Smet H, et al. Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol 2012;12:83
   PubMed Web of Science ®Google Scholar
• De Seta F, Restaino S, De Santo D, et al. Effects of hormonal contraception on vaginal flora. Contraception 2012;86:526–9
   PubMed Web of Science ®Google Scholar
• Veres S, Miller L, Burington B. A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol 2004;104:555–63
   PubMed Web of Science ®Google Scholar
• Camacho DP, Consolaro MEL, Patussi EV, et al. Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 2007;76:439–43
   PubMed Web of Science ®Google Scholar
• Lete I, Cuesta MC, Marín JM, Guerra S. Vaginal health in contraceptive vaginal ring users – A review. Eur J Contracept Reprod Health Care. 2013;18:234--41
   Google Scholar
• Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women's Well-Being and Sexuality Study. Sex Health 2008;5:321–30
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Tonani S, et al. Psychosexual well-being in women using oral contraceptives containing drospirenone. Funct Neurol 2009;24:71–5
   PubMed Web of Science ®Google Scholar
• Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med 2012;9:2213–23
   PubMed Web of Science ®Google Scholar
• Sabatini R, Cagiano R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006;74:220–3
   PubMed Web of Science ®Google Scholar
• Guida M, Di Spiezio Sardo A, et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005;20:1100–6
   PubMed Web of Science ®Google Scholar
• Gracia CR, Sammel MD, Charlesworth S, et al. Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril 2010;93:21–8
   PubMed Web of Science ®Google Scholar